Antiretroviral Drugs

Newer posts →

First-Line Antiretroviral Treatment Outcome in a Patient Presenting an HIV-1/2 Multiclass Drug Resistant Infection.

Published December 15, 2012

First-line antiretroviral treatment outcome in a patient presenting an HIV-1/2 multiclass drug resistant infection.

Filed under: Addiction Rehab

J Int AIDS Soc. 2012; 15(6): 18224
Castro E, Recordon-Pinson P, Papuchon J, Vetter B, Shah C, Schupbach J, Fleury H,… Continue reading →

Drug and Alcohol Rehabilitation: Community Capacity Assessment in Preventing Substance Abuse: A Participatory Approach.

Published November 30, 2012

Community capacity assessment in preventing substance abuse: a participatory approach.

Filed under: Drug and Alcohol Rehabilitation

Iran J Public Health. 2012; 41(9): 48-55
Shahandeh Kh, Majdzadeh R, Jamshidi E, Loori N

Community-based participatory research (CBPR) increasingly is being used… Continue reading →

Drug and Alcohol Rehabilitation: Brentuximab Vedotin.

Published November 18, 2012

Brentuximab vedotin.

Filed under: Drug and Alcohol Rehabilitation

Clin Cancer Res. 2012 Nov 15;
Deng C, Pan B, O’Connor OA

Brentuximab vedotin (SGN-35), an intravenously administered CD30-specific antibody-drug conjugate, has recently been approved by the U.S. Food and Drug… Continue reading →

Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients.

Published November 14, 2012

Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2012; 7(11): e49091
Bastard M, Pinoges L, Balkan S, Szumilin E, Ferreyra… Continue reading →

Newer posts →

Home | Contact Us | Terms of Use | Privacy Policy | Sitemap
Copyright © 2024 RehabCentersNetwork.Com. All Rights Reserved.

Designed by TrueStar Domains.